Joshua Kazam

Portfolio · 1

Entera Bio

Oral Delivery of Therapeutic Proteins

1 round $7.5M committed Latest: 2016-07

Investment activity

1 portfolio exit on record.

Q&A

What is Joshua Kazam's primary investment focus by sector?

Joshua Kazam primarily focuses on the Health Tech & Life Sciences sector, with all recorded portfolio companies and exits falling within this area.

Can you name a notable exit for Joshua Kazam?

A notable exit for Joshua Kazam is Entera Bio, which went public on NASDAQ in July 2018 with a valuation of $91M.

What is Joshua Kazam's most recent portfolio company listed?

Joshua Kazam's most recent listed portfolio company is Entera Bio, founded in 2009, which focuses on the oral delivery of therapeutic proteins.

What type of funding stage has Joshua Kazam participated in?

Joshua Kazam has participated in Convertible Debt funding rounds.

When did Joshua Kazam make his most recent recorded investment?

Joshua Kazam's most recent recorded investment activity was in July 2016.